MARKET

ICLR

ICLR

ICON PLC
NASDAQ
185.77
-2.01
-1.07%
After Hours: 184.97 -0.8 -0.43% 17:41 12/04 EST
OPEN
185.06
PREV CLOSE
187.78
HIGH
186.77
LOW
174.13
VOLUME
1.65M
TURNOVER
--
52 WEEK HIGH
228.29
52 WEEK LOW
125.10
MARKET CAP
14.19B
P/E (TTM)
25.11
1D
5D
1M
3M
1Y
5Y
1D
CROs fall as FDA head Makary says drug approvals will require fewer trials
Seeking Alpha · 10h ago
FDA shift in drug study requirements sends trial runners lower
TipRanks · 13h ago
FDA to reduce number of trials required for drug approvals, STAT reports
TipRanks · 14h ago
Icon’s Hold Rating: Navigating Leadership Transition and Customer Challenges Amid Market Recovery
TipRanks · 16h ago
Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q3 2025 Update
Seeking Alpha · 1d ago
What ICON (ICLR)'s Trial Site Bottleneck Survey Reveals About Its Evolving CRO Partnership Strategy
Simply Wall St · 1d ago
BRIEF-Icon Survey Reveals Increasing Clinical Trial Startup Delays
Reuters · 2d ago
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions
Barchart · 2d ago
More
About ICLR
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Webull offers ICON PLC stock information, including NASDAQ: ICLR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICLR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICLR stock methods without spending real money on the virtual paper trading platform.